I would like to start by asking you a question. Behind me, you see two images. Take a quick look.And if you prefer image one, please raise your hand. If you prefer image two, please raise your hand. Okay, I think that is roughly 50/50.Perfect. Let me ask you again. What about now.Who prefers image one. Who prefers image two. Okay, I don't know if you noticed some opinions just shifted a bit.Today I want to talk about this very phenomena to answer two questions. First, can AI create art which is an aesthetic ...

Core Argument - The report advocates for revitalizing ancient art forms like Miso porcelain by drawing inspiration from modern cultural trends, specifically the blind box phenomenon [2][19][20] - The central idea is that cultural heritage can be reborn by aligning it with contemporary consumption habits, making its preservation economically viable [19][20] Miso Porcelain Analysis - Miso porcelain's historical significance as a royal commodity and diplomatic gift highlights its cultural narrative and prestige [3][4][5] - The craftsmanship of Miso porcelain, with its unpredictability and risk-reward element, mirrors the excitement of blind boxes [6][7][8] - Miso porcelain's aesthetics, including its motives and glaze color, need translation into modern design language for broader appeal [9][10] Blind Box Culture Parallels - Blind box culture gains popularity through storytelling, rarity, and community-driven visual identity, similar to how Miso porcelain thrived [5][10] - The element of surprise and the desire for collectible items in blind boxes can be leveraged to introduce Miso porcelain to younger audiences [8][14][15] - The emotional and visual appeal of blind boxes outweighs utility, suggesting that Miso porcelain-themed items should be small, affordable, and collectible [13][14] Practical Application & Research - The author visited museums and workshops to learn about Miso porcelain and conducted workshops for children to promote awareness [11][12] - A survey revealed that 58% of respondents had heard of Sladden, but only 19% were familiar with Miso porcelain, indicating a gap in awareness [13] - Designs for modern Miso porcelain products draw inspiration from authentic shards, translating traditional motives into wearable items [15][16][17] Proposed Strategies - Create Miso porcelain-themed blind box items like keychains or magnets with different patterns and glaze shades [14][15] - Translate traditional Miso porcelain aesthetics into modern design language and promote them through community and social media [10][16][17] - Develop a dedicated website, "Glowing Saladin," to document, display, and spread the beauty of Miso porcelain to a global audience [18]

AI Evaluation Challenges - Current AI evaluations face problems [1] - Limitations exist in both AI and human-centric metrics for evaluating generative media [1] - Evaluating aesthetics and image/generative media is the hardest kind of AI evaluation [1] KREA.ai's Perspective - KREA.ai focuses on perceptual evaluations [1] - Krea's role involves rethinking evaluation and shaping the future of AI [1] - Krea issues a call to action regarding AI evaluation [1] Key Discussion Points - The discussion covers the historical context and compression in relation to AI evaluation [1] - The session emphasizes the importance of evaluating our evaluations [1]

Core Insights - Allergan Aesthetics is celebrating the third annual JUVÉDERM® Day on August 20, 2025, offering exclusive promotions for Allē Members, including Buy One Get One (BOGO) gift cards and a $10,000 sweepstakes [1][5][6] Company Overview - Allergan Aesthetics, a subsidiary of AbbVie, specializes in developing, manufacturing, and marketing a portfolio of leading aesthetics brands and products, including facial injectables and body contouring [9][10] Product Highlights - The JUVÉDERM® Collection is the leading hyaluronic acid filler collection in the U.S., designed to provide smooth, natural-looking results tailored to individual aesthetic goals [1][3] - The collection includes six unique formulations FDA-approved for adding volume to ten specific areas of the face [1][3] Membership and Loyalty Program - Allē, the aesthetics loyalty program from Allergan Aesthetics, has 8 million members and offers points on over 50 products and treatments across 30,000 U.S. practices [3] - Members can access exclusive savings, seasonal events, and flexible payment options through the Allē Payment Plan powered by Cherry [3][6] Event Details - JUVÉDERM® Day is held annually on the third Wednesday of August, providing an opportunity for patients to explore treatment options and take advantage of exclusive rewards [2][6] - On August 20, Allē Members can purchase a $75 JUVÉDERM® gift card and receive an additional card for free, while supplies last [6][7]

Summary of AbbVie Conference Call Company Overview - **Company**: AbbVie - **Key Executives Present**: Rob Michael (CEO), Jeff Stewart (Chief Commercial Officer), Rupal Thakkar (Chief Scientific Officer), Scott Rents (CFO) [1] Financial Performance - **Sales Growth**: AbbVie reported a 22% sales growth from its ex-Humira platform, with combined sales from SkyRizzy and Renvoke expected to exceed $25 billion this year [2] - **Revenue Guidance**: Full-year revenue guidance raised to $60.5 billion, an increase of $800 million, with adjusted EPS guidance raised by $0.21 to a range of $11.88 to $12.08 [2][14] - **Quarterly Results**: Total net revenues for the quarter were $15.4 billion, reflecting a 6.5% operational growth [13] Product Performance Immunology - **SkyRizzy**: Global sales reached $4.4 billion, up 61.8% operationally, with strong market leadership in psoriasis and IBD [3][4] - **Rinvoc**: Global sales of $2 billion, up 41.2%, with strong uptake in IBD [4][5] - **Humira**: Global sales of $1.1 billion, down 58.2% due to biosimilar competition [5] Neuroscience - **Total Revenues**: Approximately $2.7 billion, up 24% operationally [7] - **Key Products**: - Raylar: Global sales of $900 million, up 16.3% - Botox Therapeutic: Global revenues of $928 million, up 14.2% - QLIPTA: Global sales of $338 million, up 47.2% [7] Oncology - **Total Revenues**: Nearly $1.7 billion, with global sales of Imbruvica at $2.9 billion, reflecting higher persistency rates for existing patients [5][14] Aesthetics - **Total Revenues**: Nearly $1.3 billion, down 8% operationally, impacted by economic challenges [6] - **Botox Cosmetic**: Global revenues of $692 million, with growth rates down [6] Research and Development Highlights - **Pipeline Progress**: Notable approvals include Emerilis for lung cancer and RINVOC for GCA [2][8] - **Innovative Acquisitions**: Acquisition of Capstan Therapeutics for CAR T platform and Gubra for obesity treatment [3][9] - **Alopecia Areata Results**: RINVOC showed significant hair regrowth results, with 54% of patients achieving over 80% scalp coverage [8][9] Strategic Outlook - **Long-term Growth**: AbbVie is well-positioned for growth with a diversified portfolio and plans for further investments in R&D and external innovation [20][21] - **Market Dynamics**: The company is navigating competitive pressures, particularly in the IL-23 class and aesthetics market, while maintaining strong performance in its core therapeutic areas [32] Additional Insights - **Biosimilar Impact**: The transition from Humira to newer products like SkyRizzy and Rinvoc is ongoing, with some patients opting for more efficacious drugs rather than biosimilars [16][17] - **Economic Conditions**: The aesthetics market is facing challenges due to lower consumer sentiment, but AbbVie remains optimistic about long-term growth potential [6][30] Conclusion - AbbVie demonstrated strong financial performance and growth across multiple therapeutic areas, with a robust pipeline and strategic acquisitions supporting its long-term outlook. The company is actively addressing competitive dynamics and economic challenges while positioning itself for future success.

Company Overview - Tesla Fremont 工厂强调美学与功能性的结合 [1]

Workplace Design Impact - Poor workplace design can reduce productivity by as much as 20% [1] - Physical work environments actively shape how people work, think, connect, and succeed [3][4] - Aesthetics, spatial configuration, and ambient factors are key dimensions of physical work environments [5][6] Aesthetics - Aesthetics communicate a company's vision, aspirations, and identity [11][12] - Personalizing workspace aesthetics can increase employee engagement and loyalty [13][14] - Strategic use of color and texture can enhance interaction and focus [15] Spatial Configuration - Spatial configuration affects movement, interaction, and collaboration within a space [22] - Spatial layouts influence perceptions of status, fairness, and equity [25] - Strategic use of shared spaces can foster informal meetings and idea generation [26] Ambient Factors - Poor ambient conditions can erode cognitive performance by as much as 50% [29] - Bringing nature indoors, adjusting lighting, and prioritizing good air quality can improve the ambient environment [30] - Optimizing ambient factors boosts focus and decision-making [29]

Workplace Design Impact - Poor workspace design can reduce productivity by as much as 20% [1] - Physical work environments actively shape how we work, think, connect, and succeed [3] - Ambient factors can erode cognitive performance by as much as 50% [30] Three Key Dimensions of Physical Work Environments - Aesthetics: Visual sensory cues defining the work environment's aura, influencing impressions and loyalty [5][11][14] - Spatial Configuration: Layout of spaces affecting movement, interaction, and collaboration, impacting perceptions of status and fairness [6][23][26] - Ambient Factors: Unseen atmospheric characteristics like temperature, lighting, air quality, and noise levels, shaping how we feel and think [6][29] Strategies for Optimizing Workspace - Define your identity and personalize your space to increase a sense of belonging [15] - Use color and texture strategically to promote interaction and focus [15][16] - Sit near people you work with and use shared spaces for informal meetings and idea generation [27] - Prioritize good air quality and adjust lighting to match natural rhythms [31][32]

Core Insights - AbbVie reported strong first-quarter results for 2025, exceeding expectations and indicating a solid start to the year, with a focus on pipeline advancements and strategic investments [2][3] Financial Performance - First-quarter diluted EPS was $0.72 on a GAAP basis, a decrease of 6.5%, while adjusted diluted EPS was $2.46, an increase of 6.5% [3][19] - Net revenues for the first quarter reached $13.343 billion, an increase of 8.4% on a reported basis and 9.8% on an operational basis [3][4] - The immunology portfolio generated global net revenues of $6.264 billion, up 16.6% on a reported basis and 18.1% operationally [3][4] - Skyrizi net revenues were $3.425 billion, reflecting a 70.5% increase on a reported basis, while Rinvoq net revenues were $1.718 billion, up 57.2% [4][19] - Humira net revenues decreased by 50.6% to $1.121 billion [4][19] - Neuroscience portfolio revenues were $2.282 billion, an increase of 16.1% [4][19] - Oncology portfolio revenues reached $1.633 billion, up 5.8% [4][19] - Aesthetics portfolio revenues were $1.102 billion, a decrease of 11.7% [4][19] Guidance and Outlook - AbbVie raised its 2025 adjusted diluted EPS guidance from $11.99 - $12.19 to $12.09 - $12.29, accounting for an unfavorable impact of $0.13 per share related to acquired IPR&D and milestones expense [3][9] Recent Developments - The European Commission granted marketing authorization to Rinvoq for treating giant cell arteritis in adults, marking the eighth approved indication for the drug in the EU [7] - AbbVie announced a collaboration with Xilio Therapeutics to develop novel immunotherapies for cancer [7] - A Biologics License Application was submitted to the FDA for trenibotulinumtoxinE for treating moderate to severe glabellar lines, which could be the first neurotoxin of its kind available [7][8]